{"id":13037,"date":"2018-06-14T14:09:00","date_gmt":"2018-06-14T14:09:00","guid":{"rendered":"http:\/\/parkinson-export.local\/les-canadiens-atteints-de-la-maladie-de-parkinson-au-stade-avance-auront-plus-facilement-acces-a-neupro-rotigotine-comme-traitement-dappoint\/"},"modified":"2018-06-14T14:09:00","modified_gmt":"2018-06-14T18:09:00","slug":"les-canadiens-atteints-de-la-maladie-de-parkinson-au-stade-avance-auront-plus-facilement-acces-a-neupro-rotigotine-comme-traitement-dappoint","status":"publish","type":"post","link":"https:\/\/www.parkinson.ca\/fr\/les-canadiens-atteints-de-la-maladie-de-parkinson-au-stade-avance-auront-plus-facilement-acces-a-neupro-rotigotine-comme-traitement-dappoint\/","title":{"rendered":"Les Canadiens atteints de la maladie de Parkinson au stade avanc\u00e9 auront plus facilement acc\u00e8s \u00e0 NEUPRO\u00ae (rotigotine) comme traitement d&rsquo;appoint"},"content":{"rendered":"<p>UCB Canada inc. a annonc\u00e9 aujourd&rsquo;hui que NEUPRO (rotigotine), pris en compl\u00e9ment de la l\u00e9vodopa, pour le traitement de la maladie de Parkinson au stade avanc\u00e9 (MPa), est d\u00e9sormais rembours\u00e9 par tous les r\u00e9gimes publics du Canada* (sur autorisation sp\u00e9ciale). La maladie de Parkinson est une affection neurod\u00e9g\u00e9n\u00e9rative1 qui touche environ 100 000 Canadiens.  Bien qu&rsquo;il n&rsquo;existe actuellement pas de traitement curatif pour la MP, certains m\u00e9dicaments peuvent en att\u00e9nuer les sympt\u00f4mes invalidants.<\/p>\n<p><a href=\"https:\/\/www.newswire.ca\/fr\/news-releases\/les-canadiens-atteints-de-la-maladie-de-parkinson-au-stade-avance-auront-plus-facilement-acces-a-neupro-rotigotine-comme-traitement-dappoint-685349131.html\" rel=\"noopener\" target=\"_blank\">Cliquez ici<\/a> pour en savoir plus.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>UCB Canada inc. a annonc\u00e9 aujourd&rsquo;hui que NEUPRO (rotigotine), pris en compl\u00e9ment de la l\u00e9vodopa, pour le traitement de la maladie de Parkinson au stade avanc\u00e9 (MPa), est d\u00e9sormais rembours\u00e9 par tous les r\u00e9gimes publics du Canada* (sur autorisation sp\u00e9ciale). La maladie de Parkinson est une affection neurod\u00e9g\u00e9n\u00e9rative1 qui touche environ 100 000 Canadiens. Bien [&hellip;]<\/p>\n","protected":false},"author":21,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[64],"tags":[],"audience":[],"class_list":["post-13037","post","type-post","status-publish","format-standard","hentry","category-actualites"],"acf":[],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 4.9.9 - aioseo.com -->\n\t<meta name=\"description\" content=\"UCB Canada inc. a annonc\u00e9 aujourd&#039;hui que NEUPRO (rotigotine), pris en compl\u00e9ment de la l\u00e9vodopa, pour le traitement de la maladie de Parkinson au stade avanc\u00e9 (MPa), est d\u00e9sormais rembours\u00e9 par tous les r\u00e9gimes publics du Canada* (sur autorisation sp\u00e9ciale). La maladie de Parkinson est une affection neurod\u00e9g\u00e9n\u00e9rative1 qui touche environ 100 000 Canadiens. Bien\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"web.project@parkinson.ca\"\/>\n\t<meta name=\"google-site-verification\" content=\"2AhivUiST2eKQcfei6JBM5Zbf8YQRvHy0kRBp9sDLWo\" \/>\n\t<link rel=\"canonical\" href=\"https:\/\/www.parkinson.ca\/fr\/les-canadiens-atteints-de-la-maladie-de-parkinson-au-stade-avance-auront-plus-facilement-acces-a-neupro-rotigotine-comme-traitement-dappoint\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 4.9.9\" \/>\n\t\t<meta property=\"og:locale\" content=\"fr_FR\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Parkinson Canada -\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Les Canadiens atteints de la maladie de Parkinson au stade avanc\u00e9 auront plus facilement acc\u00e8s \u00e0 NEUPRO\u00ae (rotigotine) comme traitement d\u2019appoint - Parkinson Canada\" \/>\n\t\t<meta property=\"og:description\" content=\"UCB Canada inc. a annonc\u00e9 aujourd&#039;hui que NEUPRO (rotigotine), pris en compl\u00e9ment de la l\u00e9vodopa, pour le traitement de la maladie de Parkinson au stade avanc\u00e9 (MPa), est d\u00e9sormais rembours\u00e9 par tous les r\u00e9gimes publics du Canada* (sur autorisation sp\u00e9ciale). La maladie de Parkinson est une affection neurod\u00e9g\u00e9n\u00e9rative1 qui touche environ 100 000 Canadiens. Bien\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/www.parkinson.ca\/fr\/les-canadiens-atteints-de-la-maladie-de-parkinson-au-stade-avance-auront-plus-facilement-acces-a-neupro-rotigotine-comme-traitement-dappoint\/\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/www.parkinson.ca\/wp-content\/uploads\/2025\/02\/Parkinson-Canada-featured-image.png\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/www.parkinson.ca\/wp-content\/uploads\/2025\/02\/Parkinson-Canada-featured-image.png\" \/>\n\t\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2018-06-14T14:09:00+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2018-06-14T18:09:00+00:00\" \/>\n\t\t<meta property=\"article:publisher\" content=\"https:\/\/facebook.com\/parkinsoncanada\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:site\" content=\"@parkinsoncanada\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Les Canadiens atteints de la maladie de Parkinson au stade avanc\u00e9 auront plus facilement acc\u00e8s \u00e0 NEUPRO\u00ae (rotigotine) comme traitement d\u2019appoint - Parkinson Canada\" \/>\n\t\t<meta name=\"twitter:description\" content=\"UCB Canada inc. a annonc\u00e9 aujourd&#039;hui que NEUPRO (rotigotine), pris en compl\u00e9ment de la l\u00e9vodopa, pour le traitement de la maladie de Parkinson au stade avanc\u00e9 (MPa), est d\u00e9sormais rembours\u00e9 par tous les r\u00e9gimes publics du Canada* (sur autorisation sp\u00e9ciale). La maladie de Parkinson est une affection neurod\u00e9g\u00e9n\u00e9rative1 qui touche environ 100 000 Canadiens. Bien\" \/>\n\t\t<meta name=\"twitter:creator\" content=\"@parkinsoncanada\" \/>\n\t\t<meta name=\"twitter:image\" content=\"https:\/\/www.parkinson.ca\/wp-content\/uploads\/2025\/02\/Parkinson-Canada-featured-image.png\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BlogPosting\",\"@id\":\"https:\\\/\\\/www.parkinson.ca\\\/fr\\\/les-canadiens-atteints-de-la-maladie-de-parkinson-au-stade-avance-auront-plus-facilement-acces-a-neupro-rotigotine-comme-traitement-dappoint\\\/#blogposting\",\"name\":\"Les Canadiens atteints de la maladie de Parkinson au stade avanc\\u00e9 auront plus facilement acc\\u00e8s \\u00e0 NEUPRO\\u00ae (rotigotine) comme traitement d\\u2019appoint - Parkinson Canada\",\"headline\":\"Les Canadiens atteints de la maladie de Parkinson au stade avanc\\u00e9 auront plus facilement acc\\u00e8s \\u00e0 NEUPRO\\u00ae (rotigotine) comme traitement d&rsquo;appoint\",\"author\":{\"@id\":\"https:\\\/\\\/www.parkinson.ca\\\/fr\\\/author\\\/webprojectparkinsonca\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/www.parkinson.ca\\\/fr\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/parkinson.ca\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/Parkinson-Canada-logo-23-RGB.jpg\",\"@id\":\"https:\\\/\\\/www.parkinson.ca\\\/fr\\\/#articleImage\"},\"datePublished\":\"2018-06-14T14:09:00+00:00\",\"dateModified\":\"2018-06-14T14:09:00+00:00\",\"inLanguage\":\"fr-FR\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.parkinson.ca\\\/fr\\\/les-canadiens-atteints-de-la-maladie-de-parkinson-au-stade-avance-auront-plus-facilement-acces-a-neupro-rotigotine-comme-traitement-dappoint\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.parkinson.ca\\\/fr\\\/les-canadiens-atteints-de-la-maladie-de-parkinson-au-stade-avance-auront-plus-facilement-acces-a-neupro-rotigotine-comme-traitement-dappoint\\\/#webpage\"},\"articleSection\":\"Actualit\\u00e9s, Facultatif\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.parkinson.ca\\\/fr\\\/les-canadiens-atteints-de-la-maladie-de-parkinson-au-stade-avance-auront-plus-facilement-acces-a-neupro-rotigotine-comme-traitement-dappoint\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.parkinson.ca\\\/fr\\\/#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.parkinson.ca\\\/fr\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.parkinson.ca\\\/fr\\\/category\\\/actualites\\\/#listItem\",\"name\":\"Actualit\\u00e9s\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.parkinson.ca\\\/fr\\\/category\\\/actualites\\\/#listItem\",\"position\":2,\"name\":\"Actualit\\u00e9s\",\"item\":\"https:\\\/\\\/www.parkinson.ca\\\/fr\\\/category\\\/actualites\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.parkinson.ca\\\/fr\\\/les-canadiens-atteints-de-la-maladie-de-parkinson-au-stade-avance-auront-plus-facilement-acces-a-neupro-rotigotine-comme-traitement-dappoint\\\/#listItem\",\"name\":\"Les Canadiens atteints de la maladie de Parkinson au stade avanc\\u00e9 auront plus facilement acc\\u00e8s \\u00e0 NEUPRO\\u00ae (rotigotine) comme traitement d&rsquo;appoint\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.parkinson.ca\\\/fr\\\/#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.parkinson.ca\\\/fr\\\/les-canadiens-atteints-de-la-maladie-de-parkinson-au-stade-avance-auront-plus-facilement-acces-a-neupro-rotigotine-comme-traitement-dappoint\\\/#listItem\",\"position\":3,\"name\":\"Les Canadiens atteints de la maladie de Parkinson au stade avanc\\u00e9 auront plus facilement acc\\u00e8s \\u00e0 NEUPRO\\u00ae (rotigotine) comme traitement d&rsquo;appoint\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.parkinson.ca\\\/fr\\\/category\\\/actualites\\\/#listItem\",\"name\":\"Actualit\\u00e9s\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.parkinson.ca\\\/fr\\\/#organization\",\"name\":\"Parkinson Canada\",\"description\":\"Parkinson Canada empowers people living with Parkinson\\u2019s and their care partners to thrive. Through advocacy, education, and support, we work to improve access to care, advance research, and build a stronger Parkinson\\u2019s community across Canada. Join us in making a difference.\",\"url\":\"https:\\\/\\\/www.parkinson.ca\\\/fr\\\/\",\"email\":\"info@parkinson.ca\",\"telephone\":\"+18005653000\",\"foundingDate\":\"1965-04-11\",\"numberOfEmployees\":{\"@type\":\"QuantitativeValue\",\"minValue\":50,\"maxValue\":100},\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/parkinson.ca\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/Parkinson-Canada-logo-23-RGB.jpg\",\"@id\":\"https:\\\/\\\/www.parkinson.ca\\\/fr\\\/les-canadiens-atteints-de-la-maladie-de-parkinson-au-stade-avance-auront-plus-facilement-acces-a-neupro-rotigotine-comme-traitement-dappoint\\\/#organizationLogo\"},\"image\":{\"@id\":\"https:\\\/\\\/www.parkinson.ca\\\/fr\\\/les-canadiens-atteints-de-la-maladie-de-parkinson-au-stade-avance-auront-plus-facilement-acces-a-neupro-rotigotine-comme-traitement-dappoint\\\/#organizationLogo\"},\"sameAs\":[\"https:\\\/\\\/facebook.com\\\/parkinsoncanada\",\"https:\\\/\\\/twitter.com\\\/parkinsoncanada\",\"https:\\\/\\\/instagram.com\\\/parkinsoncanada\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCm_sAjRqhAaiutx2B9dOqng\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/parkinson-canada\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.parkinson.ca\\\/fr\\\/author\\\/webprojectparkinsonca\\\/#author\",\"url\":\"https:\\\/\\\/www.parkinson.ca\\\/fr\\\/author\\\/webprojectparkinsonca\\\/\",\"name\":\"web.project@parkinson.ca\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/www.parkinson.ca\\\/fr\\\/les-canadiens-atteints-de-la-maladie-de-parkinson-au-stade-avance-auront-plus-facilement-acces-a-neupro-rotigotine-comme-traitement-dappoint\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e19090b3650acb221d17e3b54e1e923a4a958f690d6e0fe3a797be2a980ee83e?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"web.project@parkinson.ca\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.parkinson.ca\\\/fr\\\/les-canadiens-atteints-de-la-maladie-de-parkinson-au-stade-avance-auront-plus-facilement-acces-a-neupro-rotigotine-comme-traitement-dappoint\\\/#webpage\",\"url\":\"https:\\\/\\\/www.parkinson.ca\\\/fr\\\/les-canadiens-atteints-de-la-maladie-de-parkinson-au-stade-avance-auront-plus-facilement-acces-a-neupro-rotigotine-comme-traitement-dappoint\\\/\",\"name\":\"Les Canadiens atteints de la maladie de Parkinson au stade avanc\\u00e9 auront plus facilement acc\\u00e8s \\u00e0 NEUPRO\\u00ae (rotigotine) comme traitement d\\u2019appoint - Parkinson Canada\",\"description\":\"UCB Canada inc. a annonc\\u00e9 aujourd'hui que NEUPRO (rotigotine), pris en compl\\u00e9ment de la l\\u00e9vodopa, pour le traitement de la maladie de Parkinson au stade avanc\\u00e9 (MPa), est d\\u00e9sormais rembours\\u00e9 par tous les r\\u00e9gimes publics du Canada* (sur autorisation sp\\u00e9ciale). La maladie de Parkinson est une affection neurod\\u00e9g\\u00e9n\\u00e9rative1 qui touche environ 100 000 Canadiens. Bien\",\"inLanguage\":\"fr-FR\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.parkinson.ca\\\/fr\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.parkinson.ca\\\/fr\\\/les-canadiens-atteints-de-la-maladie-de-parkinson-au-stade-avance-auront-plus-facilement-acces-a-neupro-rotigotine-comme-traitement-dappoint\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/www.parkinson.ca\\\/fr\\\/author\\\/webprojectparkinsonca\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/www.parkinson.ca\\\/fr\\\/author\\\/webprojectparkinsonca\\\/#author\"},\"datePublished\":\"2018-06-14T14:09:00+00:00\",\"dateModified\":\"2018-06-14T14:09:00+00:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.parkinson.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.parkinson.ca\\\/fr\\\/\",\"name\":\"Parkinson Canada\",\"inLanguage\":\"fr-FR\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.parkinson.ca\\\/fr\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Les Canadiens atteints de la maladie de Parkinson au stade avanc\u00e9 auront plus facilement acc\u00e8s \u00e0 NEUPRO\u00ae (rotigotine) comme traitement d\u2019appoint - Parkinson Canada","description":"UCB Canada inc. a annonc\u00e9 aujourd'hui que NEUPRO (rotigotine), pris en compl\u00e9ment de la l\u00e9vodopa, pour le traitement de la maladie de Parkinson au stade avanc\u00e9 (MPa), est d\u00e9sormais rembours\u00e9 par tous les r\u00e9gimes publics du Canada* (sur autorisation sp\u00e9ciale). La maladie de Parkinson est une affection neurod\u00e9g\u00e9n\u00e9rative1 qui touche environ 100 000 Canadiens. Bien","canonical_url":"https:\/\/www.parkinson.ca\/fr\/les-canadiens-atteints-de-la-maladie-de-parkinson-au-stade-avance-auront-plus-facilement-acces-a-neupro-rotigotine-comme-traitement-dappoint\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"google-site-verification":"2AhivUiST2eKQcfei6JBM5Zbf8YQRvHy0kRBp9sDLWo","miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BlogPosting","@id":"https:\/\/www.parkinson.ca\/fr\/les-canadiens-atteints-de-la-maladie-de-parkinson-au-stade-avance-auront-plus-facilement-acces-a-neupro-rotigotine-comme-traitement-dappoint\/#blogposting","name":"Les Canadiens atteints de la maladie de Parkinson au stade avanc\u00e9 auront plus facilement acc\u00e8s \u00e0 NEUPRO\u00ae (rotigotine) comme traitement d\u2019appoint - Parkinson Canada","headline":"Les Canadiens atteints de la maladie de Parkinson au stade avanc\u00e9 auront plus facilement acc\u00e8s \u00e0 NEUPRO\u00ae (rotigotine) comme traitement d&rsquo;appoint","author":{"@id":"https:\/\/www.parkinson.ca\/fr\/author\/webprojectparkinsonca\/#author"},"publisher":{"@id":"https:\/\/www.parkinson.ca\/fr\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/parkinson.ca\/wp-content\/uploads\/2025\/01\/Parkinson-Canada-logo-23-RGB.jpg","@id":"https:\/\/www.parkinson.ca\/fr\/#articleImage"},"datePublished":"2018-06-14T14:09:00+00:00","dateModified":"2018-06-14T14:09:00+00:00","inLanguage":"fr-FR","mainEntityOfPage":{"@id":"https:\/\/www.parkinson.ca\/fr\/les-canadiens-atteints-de-la-maladie-de-parkinson-au-stade-avance-auront-plus-facilement-acces-a-neupro-rotigotine-comme-traitement-dappoint\/#webpage"},"isPartOf":{"@id":"https:\/\/www.parkinson.ca\/fr\/les-canadiens-atteints-de-la-maladie-de-parkinson-au-stade-avance-auront-plus-facilement-acces-a-neupro-rotigotine-comme-traitement-dappoint\/#webpage"},"articleSection":"Actualit\u00e9s, Facultatif"},{"@type":"BreadcrumbList","@id":"https:\/\/www.parkinson.ca\/fr\/les-canadiens-atteints-de-la-maladie-de-parkinson-au-stade-avance-auront-plus-facilement-acces-a-neupro-rotigotine-comme-traitement-dappoint\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/www.parkinson.ca\/fr\/#listItem","position":1,"name":"Home","item":"https:\/\/www.parkinson.ca\/fr\/","nextItem":{"@type":"ListItem","@id":"https:\/\/www.parkinson.ca\/fr\/category\/actualites\/#listItem","name":"Actualit\u00e9s"}},{"@type":"ListItem","@id":"https:\/\/www.parkinson.ca\/fr\/category\/actualites\/#listItem","position":2,"name":"Actualit\u00e9s","item":"https:\/\/www.parkinson.ca\/fr\/category\/actualites\/","nextItem":{"@type":"ListItem","@id":"https:\/\/www.parkinson.ca\/fr\/les-canadiens-atteints-de-la-maladie-de-parkinson-au-stade-avance-auront-plus-facilement-acces-a-neupro-rotigotine-comme-traitement-dappoint\/#listItem","name":"Les Canadiens atteints de la maladie de Parkinson au stade avanc\u00e9 auront plus facilement acc\u00e8s \u00e0 NEUPRO\u00ae (rotigotine) comme traitement d&rsquo;appoint"},"previousItem":{"@type":"ListItem","@id":"https:\/\/www.parkinson.ca\/fr\/#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/www.parkinson.ca\/fr\/les-canadiens-atteints-de-la-maladie-de-parkinson-au-stade-avance-auront-plus-facilement-acces-a-neupro-rotigotine-comme-traitement-dappoint\/#listItem","position":3,"name":"Les Canadiens atteints de la maladie de Parkinson au stade avanc\u00e9 auront plus facilement acc\u00e8s \u00e0 NEUPRO\u00ae (rotigotine) comme traitement d&rsquo;appoint","previousItem":{"@type":"ListItem","@id":"https:\/\/www.parkinson.ca\/fr\/category\/actualites\/#listItem","name":"Actualit\u00e9s"}}]},{"@type":"Organization","@id":"https:\/\/www.parkinson.ca\/fr\/#organization","name":"Parkinson Canada","description":"Parkinson Canada empowers people living with Parkinson\u2019s and their care partners to thrive. Through advocacy, education, and support, we work to improve access to care, advance research, and build a stronger Parkinson\u2019s community across Canada. Join us in making a difference.","url":"https:\/\/www.parkinson.ca\/fr\/","email":"info@parkinson.ca","telephone":"+18005653000","foundingDate":"1965-04-11","numberOfEmployees":{"@type":"QuantitativeValue","minValue":50,"maxValue":100},"logo":{"@type":"ImageObject","url":"https:\/\/parkinson.ca\/wp-content\/uploads\/2025\/01\/Parkinson-Canada-logo-23-RGB.jpg","@id":"https:\/\/www.parkinson.ca\/fr\/les-canadiens-atteints-de-la-maladie-de-parkinson-au-stade-avance-auront-plus-facilement-acces-a-neupro-rotigotine-comme-traitement-dappoint\/#organizationLogo"},"image":{"@id":"https:\/\/www.parkinson.ca\/fr\/les-canadiens-atteints-de-la-maladie-de-parkinson-au-stade-avance-auront-plus-facilement-acces-a-neupro-rotigotine-comme-traitement-dappoint\/#organizationLogo"},"sameAs":["https:\/\/facebook.com\/parkinsoncanada","https:\/\/twitter.com\/parkinsoncanada","https:\/\/instagram.com\/parkinsoncanada","https:\/\/www.youtube.com\/channel\/UCm_sAjRqhAaiutx2B9dOqng","https:\/\/www.linkedin.com\/company\/parkinson-canada"]},{"@type":"Person","@id":"https:\/\/www.parkinson.ca\/fr\/author\/webprojectparkinsonca\/#author","url":"https:\/\/www.parkinson.ca\/fr\/author\/webprojectparkinsonca\/","name":"web.project@parkinson.ca","image":{"@type":"ImageObject","@id":"https:\/\/www.parkinson.ca\/fr\/les-canadiens-atteints-de-la-maladie-de-parkinson-au-stade-avance-auront-plus-facilement-acces-a-neupro-rotigotine-comme-traitement-dappoint\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/e19090b3650acb221d17e3b54e1e923a4a958f690d6e0fe3a797be2a980ee83e?s=96&d=mm&r=g","width":96,"height":96,"caption":"web.project@parkinson.ca"}},{"@type":"WebPage","@id":"https:\/\/www.parkinson.ca\/fr\/les-canadiens-atteints-de-la-maladie-de-parkinson-au-stade-avance-auront-plus-facilement-acces-a-neupro-rotigotine-comme-traitement-dappoint\/#webpage","url":"https:\/\/www.parkinson.ca\/fr\/les-canadiens-atteints-de-la-maladie-de-parkinson-au-stade-avance-auront-plus-facilement-acces-a-neupro-rotigotine-comme-traitement-dappoint\/","name":"Les Canadiens atteints de la maladie de Parkinson au stade avanc\u00e9 auront plus facilement acc\u00e8s \u00e0 NEUPRO\u00ae (rotigotine) comme traitement d\u2019appoint - Parkinson Canada","description":"UCB Canada inc. a annonc\u00e9 aujourd'hui que NEUPRO (rotigotine), pris en compl\u00e9ment de la l\u00e9vodopa, pour le traitement de la maladie de Parkinson au stade avanc\u00e9 (MPa), est d\u00e9sormais rembours\u00e9 par tous les r\u00e9gimes publics du Canada* (sur autorisation sp\u00e9ciale). La maladie de Parkinson est une affection neurod\u00e9g\u00e9n\u00e9rative1 qui touche environ 100 000 Canadiens. Bien","inLanguage":"fr-FR","isPartOf":{"@id":"https:\/\/www.parkinson.ca\/fr\/#website"},"breadcrumb":{"@id":"https:\/\/www.parkinson.ca\/fr\/les-canadiens-atteints-de-la-maladie-de-parkinson-au-stade-avance-auront-plus-facilement-acces-a-neupro-rotigotine-comme-traitement-dappoint\/#breadcrumblist"},"author":{"@id":"https:\/\/www.parkinson.ca\/fr\/author\/webprojectparkinsonca\/#author"},"creator":{"@id":"https:\/\/www.parkinson.ca\/fr\/author\/webprojectparkinsonca\/#author"},"datePublished":"2018-06-14T14:09:00+00:00","dateModified":"2018-06-14T14:09:00+00:00"},{"@type":"WebSite","@id":"https:\/\/www.parkinson.ca\/fr\/#website","url":"https:\/\/www.parkinson.ca\/fr\/","name":"Parkinson Canada","inLanguage":"fr-FR","publisher":{"@id":"https:\/\/www.parkinson.ca\/fr\/#organization"}}]},"og:locale":"fr_FR","og:site_name":"Parkinson Canada -","og:type":"article","og:title":"Les Canadiens atteints de la maladie de Parkinson au stade avanc\u00e9 auront plus facilement acc\u00e8s \u00e0 NEUPRO\u00ae (rotigotine) comme traitement d\u2019appoint - Parkinson Canada","og:description":"UCB Canada inc. a annonc\u00e9 aujourd'hui que NEUPRO (rotigotine), pris en compl\u00e9ment de la l\u00e9vodopa, pour le traitement de la maladie de Parkinson au stade avanc\u00e9 (MPa), est d\u00e9sormais rembours\u00e9 par tous les r\u00e9gimes publics du Canada* (sur autorisation sp\u00e9ciale). La maladie de Parkinson est une affection neurod\u00e9g\u00e9n\u00e9rative1 qui touche environ 100 000 Canadiens. Bien","og:url":"https:\/\/www.parkinson.ca\/fr\/les-canadiens-atteints-de-la-maladie-de-parkinson-au-stade-avance-auront-plus-facilement-acces-a-neupro-rotigotine-comme-traitement-dappoint\/","og:image":"https:\/\/www.parkinson.ca\/wp-content\/uploads\/2025\/02\/Parkinson-Canada-featured-image.png","og:image:secure_url":"https:\/\/www.parkinson.ca\/wp-content\/uploads\/2025\/02\/Parkinson-Canada-featured-image.png","og:image:width":1000,"og:image:height":600,"article:published_time":"2018-06-14T14:09:00+00:00","article:modified_time":"2018-06-14T18:09:00+00:00","article:publisher":"https:\/\/facebook.com\/parkinsoncanada","twitter:card":"summary_large_image","twitter:site":"@parkinsoncanada","twitter:title":"Les Canadiens atteints de la maladie de Parkinson au stade avanc\u00e9 auront plus facilement acc\u00e8s \u00e0 NEUPRO\u00ae (rotigotine) comme traitement d\u2019appoint - Parkinson Canada","twitter:description":"UCB Canada inc. a annonc\u00e9 aujourd'hui que NEUPRO (rotigotine), pris en compl\u00e9ment de la l\u00e9vodopa, pour le traitement de la maladie de Parkinson au stade avanc\u00e9 (MPa), est d\u00e9sormais rembours\u00e9 par tous les r\u00e9gimes publics du Canada* (sur autorisation sp\u00e9ciale). La maladie de Parkinson est une affection neurod\u00e9g\u00e9n\u00e9rative1 qui touche environ 100 000 Canadiens. Bien","twitter:creator":"@parkinsoncanada","twitter:image":"https:\/\/www.parkinson.ca\/wp-content\/uploads\/2025\/02\/Parkinson-Canada-featured-image.png"},"aioseo_meta_data":{"post_id":"13037","title":null,"description":null,"keywords":null,"keyphrases":null,"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":null,"og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":null,"robots_max_videopreview":null,"robots_max_imagepreview":"large","priority":null,"frequency":null,"local_seo":null,"breadcrumb_settings":null,"limit_modified_date":false,"ai":null,"created":"2025-01-28 09:43:14","updated":"2025-06-07 10:06:35","seo_analyzer_scan_date":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.parkinson.ca\/fr\/\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.parkinson.ca\/fr\/category\/actualites\/\" title=\"Actualit\u00e9s\">Actualit\u00e9s<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tLes Canadiens atteints de la maladie de Parkinson au stade avanc\u00e9 auront plus facilement acc\u00e8s \u00e0 NEUPRO\u00ae (rotigotine) comme traitement d\u2019appoint\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/www.parkinson.ca\/fr\/"},{"label":"Actualit\u00e9s","link":"https:\/\/www.parkinson.ca\/fr\/category\/actualites\/"},{"label":"Les Canadiens atteints de la maladie de Parkinson au stade avanc\u00e9 auront plus facilement acc\u00e8s \u00e0 NEUPRO\u00ae (rotigotine) comme traitement d&rsquo;appoint","link":"https:\/\/www.parkinson.ca\/fr\/les-canadiens-atteints-de-la-maladie-de-parkinson-au-stade-avance-auront-plus-facilement-acces-a-neupro-rotigotine-comme-traitement-dappoint\/"}],"_links":{"self":[{"href":"https:\/\/www.parkinson.ca\/fr\/wp-json\/wp\/v2\/posts\/13037","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.parkinson.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.parkinson.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.parkinson.ca\/fr\/wp-json\/wp\/v2\/users\/21"}],"replies":[{"embeddable":true,"href":"https:\/\/www.parkinson.ca\/fr\/wp-json\/wp\/v2\/comments?post=13037"}],"version-history":[{"count":0,"href":"https:\/\/www.parkinson.ca\/fr\/wp-json\/wp\/v2\/posts\/13037\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.parkinson.ca\/fr\/wp-json\/wp\/v2\/media?parent=13037"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.parkinson.ca\/fr\/wp-json\/wp\/v2\/categories?post=13037"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.parkinson.ca\/fr\/wp-json\/wp\/v2\/tags?post=13037"},{"taxonomy":"audience","embeddable":true,"href":"https:\/\/www.parkinson.ca\/fr\/wp-json\/wp\/v2\/audience?post=13037"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}